Filing Details
- Accession Number:
- 0001209191-22-060700
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-12 16:30:29
- Reporting Period:
- 2022-12-08
- Accepted Time:
- 2022-12-12 16:30:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1841387 | Candel Therapeutics Inc. | CADL | Biological Products, (No Disgnostic Substances) (2836) | 522214851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1909680 | Francesca Barone | C/O Candel Therapeutics, Inc. 117 Kendrick St., Suite 450 Needham MA 02494 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-08 | 1,238 | $1.61 | 2,738 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
